tradingkey.logo

iSpecimen Inc

ISPC

1.530USD

+0.060+4.08%
Horarios del mercado ETCotizaciones retrasadas 15 min
3.82MCap. mercado
PérdidaP/E TTM

iSpecimen Inc

1.530

+0.060+4.08%
Más Datos de iSpecimen Inc Compañía
iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.
Información de la empresa
Símbolo de cotizaciónISPC
Nombre de la empresaiSpecimen Inc
Fecha de salida a bolsaJun 17, 2021
Director ejecutivoMr. Robert Bradley Lim
Número de empleados24
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 17
Dirección8 Cabot Road
CiudadWOBURN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal08101
Teléfono17813016700
Sitio Webhttps://www.ispecimen.com/
Símbolo de cotizaciónISPC
Fecha de salida a bolsaJun 17, 2021
Director ejecutivoMr. Robert Bradley Lim
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Mr. Robert Bradley Lim
Mr. Robert Bradley Lim
Chief Executive Officer, Treasurer, Secretary, Director
Chief Executive Officer, Treasurer, Secretary, Director
--
--
Mr. Yuying Liang
Mr. Yuying Liang
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President
President
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Mr. Robert Bradley Lim
Mr. Robert Bradley Lim
Chief Executive Officer, Treasurer, Secretary, Director
Chief Executive Officer, Treasurer, Secretary, Director
--
--
Mr. Yuying Liang
Mr. Yuying Liang
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President
President
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Specimens – contracts with customers
976.97K
92.38%
Shipping and other
80.54K
7.62%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Specimens – contracts with customers
976.97K
92.38%
Shipping and other
80.54K
7.62%
Estadísticas de accionistas
Actualizado: dom., 27 de jul
Actualizado: dom., 27 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
OBF Investments LLC
1.69%
Wolf (James G)
1.01%
Bridgeway Capital Management, LLC
0.87%
UBS Financial Services, Inc.
0.87%
Geode Capital Management, L.L.C.
0.43%
Other
95.13%
Accionistas
Accionistas
Proporción
OBF Investments LLC
1.69%
Wolf (James G)
1.01%
Bridgeway Capital Management, LLC
0.87%
UBS Financial Services, Inc.
0.87%
Geode Capital Management, L.L.C.
0.43%
Other
95.13%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
1.93%
Corporation
1.69%
Individual Investor
1.02%
Investment Advisor/Hedge Fund
0.43%
Hedge Fund
0.12%
Other
94.82%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
31
129.44K
5.18%
-38.53K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
2023Q2
48
208.72K
46.34%
-34.91K
2023Q1
47
214.33K
47.61%
-27.06K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
OBF Investments LLC
42.10K
1.69%
+1.00
+0.00%
Dec 31, 2024
Wolf (James G)
25.25K
1.01%
-14.29K
-36.14%
Jun 03, 2024
Bridgeway Capital Management, LLC
21.80K
0.87%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
21.71K
0.87%
+10.74K
+97.84%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.73K
0.43%
+10.73K
--
Mar 31, 2025
Tower Research Capital LLC
2.98K
0.12%
+2.85K
+2175.57%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.83K
0.11%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
1.80K
0.07%
--
--
May 31, 2025
Scholl (George H)
163.00
0.01%
+7.00
+4.49%
Dec 31, 2023
Brooks (John L III)
32.00
0%
-131.00
-80.37%
Apr 14, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Fecha
Tipo
Relación
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
KeyAI